Nve Corp /New/ (NVEC) Stock Analysis and Metrics

Nve

NASDAQ: NVEC

$91.31 ▲ +3.01 (+3.41%)

At close: Jul 14, 2026 · 2:16 PM UTC

Financial Ratios

Market Cap512.59 Mn

P/E29.41

P/S39.35

Div. Yield0.04

ROIC (Qtr)0.00

Add ratio to table…

About

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high performance spintronic products including sensors, couplers, and magnetic random-access memory (MRAM) devices. Its technology is based on giant magnetoresistance (GMR) and tunneling magnetoresistance (TMR) structures, where resistance changes according to the orientation of electron spin in thin ferromagnetic layers. NVE Corporation’s sensors detect position or speed in robotics and machinery, its couplers provide reliable digital communication between subsystems in factory automation, and its MRAM products offer non volatile memory for industrial and defense applications. By combining spintronic elements with conventional integrated circuitry and packaging them in standard semiconductor packages, the firm delivers components that function as the eyes, nerves, and brains of electronic systems.

NVE Corporation generates revenue primarily from the sale of its spintronic sensors, couplers, and MRAM products to original equipment manufacturers in the industrial automation, robotics, medical device, and defense sectors. Sales are conducted both directly to end users and through a network of distributors that serve factory automation and telecommunications markets. In addition, the company has received more than $50 million in government research contracts that support product development and the growth of its intellectual property portfolio. These contracts have financed advances in GMR and TMR materials, allowing thinner active layers and enhanced device sensitivity. NVE Corporation also packages its spintronic dies in standard semiconductor enclosures, making its components compatible with existing circuit board assembly processes.

NVE Corporation occupies a specialized niche within the broader electronic components market, competing with larger semiconductor companies that produce conventional sensors, isolation amplifiers, and memory products. Its competitive advantages arise from the unique physics of spintronic effects, which enable devices to be physically smaller, offer higher measurement precision, and exhibit greater long term reliability than alternatives such as Hall effect or anisotropic magnetoresistance sensors. In the coupler space, NVE Corporation’s spintronic isolators achieve higher data rates, longer transmission distances, and greater channel density than traditional optocouplers or transformer based solutions. For memory applications, its MRAM technology provides non volatile storage with faster write speeds and lower power consumption compared with flash memory, positioning it for emerging industrial and defense markets. The company’s protective intellectual property, built from over $50 million of government funded research, further shields its technology from rapid imitation.

NVE Corporation serves a diverse customer base that includes manufacturers of factory automation equipment, robotics systems, implantable medical device producers, and industrial and defense contractors requiring rugged, high performance sensing and communication solutions. Its spintronic sensors are integrated into robotic arms, motor controllers, and precision positioning systems used by automation Original Equipment Manufacturers. The company’s couplers are employed in factory communication networks, motor drive interfaces, and safety critical data links supplied to industrial machinery builders. For memory products, NVE Corporation’s MRAM dies are incorporated into secure data storage modules for military equipment, aerospace avionics, and antitamper systems utilized by defense prime contractors. While the filing does not disclose individual customer names, the company’s revenue is derived from a broad range of end users spanning North America, Europe, and Asia.

Investment Thesis

▲ Bull case

NVE Corporation's recent performance reveals a robust underlying strength in its core nondefense business that significantly outperforms the headline figures suggest, driven by a strategic pivot toward high-growth secular markets. The company reported a 34% increase in core nondefense sales for the quarter, a figure that more than compensated for the volatility in defense sales and underscores the success of its targeted investments in medical devices, electric and autonomous vehicles, and advanced robotics. This growth is not merely cyclical but reflects a structural shift as the company's miniaturized wafer-level chip-scale sensors gain traction in applications requiring extreme precision and reliability, such as implantable medical devices and surgical robots, where size and power efficiency are paramount. Management highlighted successful exhibitions at major industry events like Medical Design & Manufacturing West and Sensors Converge, generating qualified leads in these high-value segments, indicating that the sales pipeline is actively building beyond what current revenue figures capture. The strategic alignment with secular trends like the Artificial Intelligence of Things (AIoT) and the increasing demand for sensor-rich applications in automation positions NVE to capture disproportionate growth as these markets expand, independent of the unpredictable defense procurement cycles that have historically masked its underlying strength.
A significant yet underappreciated catalyst for future earnings power lies in the company's recently completed manufacturing expansion and the associated tax benefits, which are set to create a sustainable margin expansion tailwind. NVE invested $2.19 million in fixed assets during fiscal 2026 to complete a two-year, multimillion-dollar expansion, placing the final major equipment cluster into service in the quarter just reported. This expansion has not only increased capacity but also enhanced capabilities, enabling the production of smaller, more precise components like the 0.65mm wafer-level chip-scale sensor in-house, which improves margins through greater control over the production process and reduced reliance on external foundries. Critically, the company utilized the Advanced Manufacturing Investment Tax Credit, which reduced its effective tax rate to 5% for the quarter and contributed to a full-year rate of 15% for fiscal 2026, generating a substantial cash benefit including an expected $1.3 million federal tax refund. While management noted these credits will decrease in fiscal 2027 as equipment purchases wind down, the permanent reduction in the effective tax rate from the utilization of prior-year unamortized R&D expenses— which lowered quarterly estimated tax payments by $1.4 million — represents a structural, non-recurring benefit that has already been realized and will continue to support net income growth even as the credit incentive phases out, effectively lowering the hurdle for future profitability.
The company's financial profile exhibits exceptional quality and resilience, characterized by high-margin operations and strong cash generation that is being conservatively interpreted by the market despite clear signs of operating leverage. NVE reported an impressive gross margin of 78% and an operating margin of 62% for the quarter, with full-year operating margin holding steady at 60%, indicating a business model inherently resistant to inflationary pressures due to its high intellectual property content and minimal variable costs. More tellingly, cash flow from operations reached $16.7 million for the fiscal year, exceeding net income by $1.5 million and demonstrating the high quality of earnings, a metric often overlooked when focusing solely on EPS growth. This strong cash conversion was supported by a 5% reduction in inventories despite increased sales, reflecting improved operational efficiency in converting raw materials and work-in-progress into finished goods, facilitated by the new equipment. The company's balance sheet remains exceptionally strong, with minimal debt and substantial liquidity, providing ample flexibility to fund R&D, pursue strategic acquisitions, or increase shareholder returns without financial strain. This combination of high margins, efficient capital use, and robust cash flow creates a durable competitive advantage that allows NVE to reinvest in innovation during downturns while maintaining profitability, a trait that is particularly valuable as semiconductor industry sentiment improves and capital allocation favors companies with strong, self-funded growth engines.

NVE Corporation's recent performance reveals a robust underlying strength in its core nondefense business that significantly outperforms the headline figures suggest, driven by a strategic pivot toward high-growth secular markets. The company reported a 34% increase in core nondefense sales for the quarter, a figure that more than compensated for the volatility in defense sales and underscores the success of its targeted investments in medical devices, electric and autonomous vehicles, and advanced robotics. This growth is not merely cyclical but reflects a structural shift as the company's miniaturized wafer-level chip-scale sensors gain traction in applications requiring extreme precision and reliability, such as implantable medical devices and surgical robots, where size and power efficiency are paramount. Management highlighted successful exhibitions at major industry events like Medical Design & Manufacturing West and Sensors Converge, generating qualified leads in these high-value segments, indicating that the sales pipeline is actively building beyond what current revenue figures capture. The strategic alignment with secular trends like the Artificial Intelligence of Things (AIoT) and the increasing demand for sensor-rich applications in automation positions NVE to capture disproportionate growth as these markets expand, independent of the unpredictable defense procurement cycles that have historically masked its underlying strength.
A significant yet underappreciated catalyst for future earnings power lies in the company's recently completed manufacturing expansion and the associated tax benefits, which are set to create a sustainable margin expansion tailwind. NVE invested $2.19 million in fixed assets during fiscal 2026 to complete a two-year, multimillion-dollar expansion, placing the final major equipment cluster into service in the quarter just reported. This expansion has not only increased capacity but also enhanced capabilities, enabling the production of smaller, more precise components like the 0.65mm wafer-level chip-scale sensor in-house, which improves margins through greater control over the production process and reduced reliance on external foundries. Critically, the company utilized the Advanced Manufacturing Investment Tax Credit, which reduced its effective tax rate to 5% for the quarter and contributed to a full-year rate of 15% for fiscal 2026, generating a substantial cash benefit including an expected $1.3 million federal tax refund. While management noted these credits will decrease in fiscal 2027 as equipment purchases wind down, the permanent reduction in the effective tax rate from the utilization of prior-year unamortized R&D expenses— which lowered quarterly estimated tax payments by $1.4 million — represents a structural, non-recurring benefit that has already been realized and will continue to support net income growth even as the credit incentive phases out, effectively lowering the hurdle for future profitability.
The company's financial profile exhibits exceptional quality and resilience, characterized by high-margin operations and strong cash generation that is being conservatively interpreted by the market despite clear signs of operating leverage. NVE reported an impressive gross margin of 78% and an operating margin of 62% for the quarter, with full-year operating margin holding steady at 60%, indicating a business model inherently resistant to inflationary pressures due to its high intellectual property content and minimal variable costs. More tellingly, cash flow from operations reached $16.7 million for the fiscal year, exceeding net income by $1.5 million and demonstrating the high quality of earnings, a metric often overlooked when focusing solely on EPS growth. This strong cash conversion was supported by a 5% reduction in inventories despite increased sales, reflecting improved operational efficiency in converting raw materials and work-in-progress into finished goods, facilitated by the new equipment. The company's balance sheet remains exceptionally strong, with minimal debt and substantial liquidity, providing ample flexibility to fund R&D, pursue strategic acquisitions, or increase shareholder returns without financial strain. This combination of high margins, efficient capital use, and robust cash flow creates a durable competitive advantage that allows NVE to reinvest in innovation during downturns while maintaining profitability, a trait that is particularly valuable as semiconductor industry sentiment improves and capital allocation favors companies with strong, self-funded growth engines.

▼ Bear case

NVE Corporation's apparent strength in nondefense sales masks a deeply concerning and persistent reliance on volatile defense and government-related revenue streams, which constitute a significant and underappreciated risk to earnings stability that management consistently downplays. While the company highlighted a 34% increase in core nondefense sales for the quarter, this growth occurred alongside a staggering 79% year-over-year decline in defense sales and a 19% drop in contract R&D revenue—much of which is also defense- and government-related—revealing that the core business remains highly susceptible to the unpredictable timing of federal budget cycles and procurement delays. Management's characterization of defense sales as "steady[ly] recovering" and their expectation of a "significant increase this fiscal year" appears optimistic given the historical pattern of lumpiness in this segment, and the fact that contract R&D, a key indicator of future government-funded work, declined for the quarter and only saw modest annual growth of 2.4% in product sales for the fiscal year raises doubts about the sustainability of the nondefense surge. The concentration risk is further exacerbated by the company's own acknowledgment in its Safe Harbor statement of reliance on "several large customers for a significant percentage of revenue," a dynamic that makes NVE vulnerable to shifts in spending by a handful of defense contractors or government agencies, turning what appears as broad-based growth into a potentially fragile outcome dependent on macroeconomic and geopolitical factors outside its control.
The company's aggressive investment in new manufacturing capacity, while framed as a strategic advantage, carries substantial execution risk and threatens to create a significant overhang on future profitability if demand fails to materialize at the anticipated pace, a scenario that is increasingly plausible given the early-stage nature of its target markets. NVE completed a major expansion involving $2.19 million in fixed asset purchases for fiscal 2026, explicitly stating it expects such spending to "decrease significantly in 2027 with the completion of our expansion," which implies the current capacity was built anticipating a step-change in demand that has not yet been fully realized in current sales figures. Although management pointed to the new equipment enabling production of advanced products like the 0.65mm wafer-level chip-scale sensor and filling orders for high-performance TMR sensors, the utilization rate of this new capacity remains unclear, and the significant increase in finished goods inventory—despite a decrease in raw materials and WIP—suggests potential bottlenecks in final assembly or, more concerning, a buildup of unsold goods if end-market demand lags. This is particularly risky given that NVE's target applications in medical devices, robotics, and AIoT, while promising, often involve long development cycles, regulatory hurdles, and intense competition from larger semiconductor players, meaning the revenue ramp from these investments could be delayed or fall short of expectations, leaving the company with elevated depreciation costs and underutilized assets that would directly pressure margins.
NVE's reported financial strength, particularly its expanding margins and tax benefits, is heavily dependent on non-recurring and transient factors that are unlikely to persist, creating a misleading picture of sustainable earnings power that the market may be overvaluing. The company's exceptionally low effective tax rate of 5% for the quarter and 15% for the fiscal year was driven primarily by the Advanced Manufacturing Investment Tax Credit and the write-off of prior-year unamortized R&D expenses, both of which are explicitly described as temporary—management stated they "expect such credits to decrease significantly in fiscal 2027" and noted the tax benefit from prior-year R&D was a "one-time" effect tied to the 2026 tax law. Furthermore, the gross margin of 78% for the quarter, while strong, represented a decline from 79% in the prior-year period, and the full-year gross margin actually decreased to 58% from a higher base, indicating underlying pressure on core profitability that is being offset by accounting benefits rather than operational improvement. The increase in net income was also aided by a significant reduction in operating expenses due to the "reassignment of some R&D resources to manufacturing" and timing factors in SG&A, suggesting that the current cost structure may not be sustainable if R&D investment needs to be replenished to support future product pipelines. This reliance on one-time tax benefits and cost-cutting measures, rather than organic, scalable growth in high-margin sales, raises the risk that any slowdown in revenue growth could quickly expose fragility in the bottom line, especially as the company laps the easy comparisons from the prior year's depressed levels.

NVE Corporation's apparent strength in nondefense sales masks a deeply concerning and persistent reliance on volatile defense and government-related revenue streams, which constitute a significant and underappreciated risk to earnings stability that management consistently downplays. While the company highlighted a 34% increase in core nondefense sales for the quarter, this growth occurred alongside a staggering 79% year-over-year decline in defense sales and a 19% drop in contract R&D revenue—much of which is also defense- and government-related—revealing that the core business remains highly susceptible to the unpredictable timing of federal budget cycles and procurement delays. Management's characterization of defense sales as "steady[ly] recovering" and their expectation of a "significant increase this fiscal year" appears optimistic given the historical pattern of lumpiness in this segment, and the fact that contract R&D, a key indicator of future government-funded work, declined for the quarter and only saw modest annual growth of 2.4% in product sales for the fiscal year raises doubts about the sustainability of the nondefense surge. The concentration risk is further exacerbated by the company's own acknowledgment in its Safe Harbor statement of reliance on "several large customers for a significant percentage of revenue," a dynamic that makes NVE vulnerable to shifts in spending by a handful of defense contractors or government agencies, turning what appears as broad-based growth into a potentially fragile outcome dependent on macroeconomic and geopolitical factors outside its control.
The company's aggressive investment in new manufacturing capacity, while framed as a strategic advantage, carries substantial execution risk and threatens to create a significant overhang on future profitability if demand fails to materialize at the anticipated pace, a scenario that is increasingly plausible given the early-stage nature of its target markets. NVE completed a major expansion involving $2.19 million in fixed asset purchases for fiscal 2026, explicitly stating it expects such spending to "decrease significantly in 2027 with the completion of our expansion," which implies the current capacity was built anticipating a step-change in demand that has not yet been fully realized in current sales figures. Although management pointed to the new equipment enabling production of advanced products like the 0.65mm wafer-level chip-scale sensor and filling orders for high-performance TMR sensors, the utilization rate of this new capacity remains unclear, and the significant increase in finished goods inventory—despite a decrease in raw materials and WIP—suggests potential bottlenecks in final assembly or, more concerning, a buildup of unsold goods if end-market demand lags. This is particularly risky given that NVE's target applications in medical devices, robotics, and AIoT, while promising, often involve long development cycles, regulatory hurdles, and intense competition from larger semiconductor players, meaning the revenue ramp from these investments could be delayed or fall short of expectations, leaving the company with elevated depreciation costs and underutilized assets that would directly pressure margins.
NVE's reported financial strength, particularly its expanding margins and tax benefits, is heavily dependent on non-recurring and transient factors that are unlikely to persist, creating a misleading picture of sustainable earnings power that the market may be overvaluing. The company's exceptionally low effective tax rate of 5% for the quarter and 15% for the fiscal year was driven primarily by the Advanced Manufacturing Investment Tax Credit and the write-off of prior-year unamortized R&D expenses, both of which are explicitly described as temporary—management stated they "expect such credits to decrease significantly in fiscal 2027" and noted the tax benefit from prior-year R&D was a "one-time" effect tied to the 2026 tax law. Furthermore, the gross margin of 78% for the quarter, while strong, represented a decline from 79% in the prior-year period, and the full-year gross margin actually decreased to 58% from a higher base, indicating underlying pressure on core profitability that is being offset by accounting benefits rather than operational improvement. The increase in net income was also aided by a significant reduction in operating expenses due to the "reassignment of some R&D resources to manufacturing" and timing factors in SG&A, suggesting that the current cost structure may not be sustainable if R&D investment needs to be replenished to support future product pipelines. This reliance on one-time tax benefits and cost-cutting measures, rather than organic, scalable growth in high-margin sales, raises the risk that any slowdown in revenue growth could quickly expose fragility in the bottom line, especially as the company laps the easy comparisons from the prior year's depressed levels.

Peer Comparison

Companies in the Semiconductors

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	NVDA	Nvidia Corp	4,798.43 Bn	0.00 Bn	18.93	8.47 Bn
2	MU	Micron Technology Inc	1,164.41 Bn	0.00 Bn	12.90	5.72 Bn
3	AMD	Advanced Micro Devices Inc	882.18 Bn	0.00 Bn	23.55	3.22 Bn
4	INTC	Intel Corp	645.64 Bn	0.00 Bn	12.01	45.03 Bn
5	ALMU	Aeluma, Inc.	370.26 Bn	0.00 Bn	71,258.42	-
6	ARM	Arm Holdings Plc /Uk	358.73 Bn	427.06 Bn	72.91	-
7	TXN	Texas Instruments Inc	271.25 Bn	0.00 Bn	14.71	14.05 Bn
8	MRVL	Marvell Technology, Inc.	239.95 Bn	0.00 Bn	27.53	4.96 Bn

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2022)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2022)

Peer Comparison

Create an account

Sign In

Reset Password